You may be right, CC is just it's not our fault and then they again "discuss the performance of leronlimab in its clinical trials" and how much they like it which would mean they didn't learn from the last CC after which the SP went into the tank.

This group seems smarter than that so I'm betting they mention things are moving along, market hours or not.